Your browser doesn't support javascript.
loading
Evaluation of In Vitro Tools to Predict the In Vivo Absorption of Biopharmaceuticals Following Subcutaneous Administration.
Bender, Christian; Eichling, Sabine; Franzen, Lutz; Herzog, Viktoria; Ickenstein, Ludger M; Jere, Dhananjay; Nonis, Lara; Schwach, Gregoire; Stoll, Philipp; Venczel, Marta; Zenk, Shalin.
Afiliação
  • Bender C; Bayer AG, Pharmaceuticals, Research & Development, Building 0520, 42096 Wuppertal, Germany. Electronic address: christian.bender@bayer.com.
  • Eichling S; AbbVie Deutschland GmbH & Co. KG, NBE Advanced Formulation Development, Building 11, 67061 Ludwigshafen, Germany.
  • Franzen L; Bayer AG, Pharmaceuticals, Research & Development, Building 0226, 23096, 42096 Wuppertal, Germany.
  • Herzog V; AbbVie Deutschland GmbH & Co. KG, NBE Advanced Formulation Development, Building 11, 67061 Ludwigshafen, Germany.
  • Ickenstein LM; Boehringer Ingelheim Pharma GmbH & Co. KG, Pharmaceutical Development Biologicals, Building G55, Birkendorfer Straße 65, 88397 Biberach an der Riss, Germany.
  • Jere D; Drug Product Services, Lonza AG, Hochbergerstrasse 60G, CH-4057 Basel, Switzerland.
  • Nonis L; Drug Product Services, Lonza AG, Hochbergerstrasse 60G, CH-4057 Basel, Switzerland.
  • Schwach G; F.Hoffmann-La Roche Ltd., Pharmaceutical Development and Supplies Europe Biologics, Grenzacherstrasse 124, 4070 Basel, Switzerland.
  • Stoll P; Boehringer Ingelheim Pharma GmbH & Co. KG, Pharmaceutical Development Biologicals, Building G55, Birkendorfer Straße 65, 88397 Biberach an der Riss, Germany.
  • Venczel M; Sanofi-Aventis Deutschland, Global CMC Development, Industriepark Hoechst, Building H770, 65926 Frankfurt am Main, Germany.
  • Zenk S; Sanofi-Aventis Deutschland, Global CMC Development, Industriepark Hoechst, Building H770, 65926 Frankfurt am Main, Germany.
J Pharm Sci ; 111(9): 2514-2524, 2022 09.
Article em En | MEDLINE | ID: mdl-35429492

Texto completo: 1 Coleções: 01-internacional Temas: Acesso_medicamentos_insumos_estrategicos Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Produtos Biológicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: J Pharm Sci Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Acesso_medicamentos_insumos_estrategicos Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Produtos Biológicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: J Pharm Sci Ano de publicação: 2022 Tipo de documento: Article